[go: up one dir, main page]

WO2002002146A3 - Medicaments - Google Patents

Medicaments Download PDF

Info

Publication number
WO2002002146A3
WO2002002146A3 PCT/GB2001/002886 GB0102886W WO0202146A3 WO 2002002146 A3 WO2002002146 A3 WO 2002002146A3 GB 0102886 W GB0102886 W GB 0102886W WO 0202146 A3 WO0202146 A3 WO 0202146A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
amphotericin
dextrin
conjugates
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2001/002886
Other languages
English (en)
Other versions
WO2002002146A2 (fr
Inventor
Sunil Shaunak
Ruth Duncan
Lisa German
Dale Hreczuk-Hirst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innovata Ltd
Original Assignee
ML Laboratories PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0016134A external-priority patent/GB0016134D0/en
Priority claimed from GB0022156A external-priority patent/GB0022156D0/en
Application filed by ML Laboratories PLC filed Critical ML Laboratories PLC
Priority to AU2001266201A priority Critical patent/AU2001266201A1/en
Priority to EP01943663A priority patent/EP1296719A2/fr
Publication of WO2002002146A2 publication Critical patent/WO2002002146A2/fr
Publication of WO2002002146A3 publication Critical patent/WO2002002146A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

L'invention concerne un composé représenté par la formule générale (I) dans laquelle GP est un polymère de glucose, ou un mélange de polymères de glucose, et éventuellement des sels de ces derniers; AF est un agent antifongique; et n est un entier de 1 à 12. L'invention concerne également des compositions contenant ce composé et des méthodes de traitement associées.
PCT/GB2001/002886 2000-07-01 2001-07-02 Medicaments Ceased WO2002002146A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2001266201A AU2001266201A1 (en) 2000-07-01 2001-07-02 Medicaments
EP01943663A EP1296719A2 (fr) 2000-07-01 2001-07-02 Medicaments

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0016134A GB0016134D0 (en) 2000-07-01 2000-07-01 Medicaments
GB0016134.9 2000-07-01
GB0022156.4 2000-09-09
GB0022156A GB0022156D0 (en) 2000-09-09 2000-09-09 Medicaments

Publications (2)

Publication Number Publication Date
WO2002002146A2 WO2002002146A2 (fr) 2002-01-10
WO2002002146A3 true WO2002002146A3 (fr) 2002-06-13

Family

ID=26244576

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2001/002886 Ceased WO2002002146A2 (fr) 2000-07-01 2001-07-02 Medicaments

Country Status (3)

Country Link
EP (1) EP1296719A2 (fr)
AU (1) AU2001266201A1 (fr)
WO (1) WO2002002146A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7220414B2 (en) 2000-09-06 2007-05-22 A.P. Pharma, Inc. Degradable polyacetal polymers

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10129369C1 (de) * 2001-06-21 2003-03-06 Fresenius Kabi De Gmbh Wasserlösliches, einen Aminozucker aufweisendes Antibiotikum in Form eines Pol ysaccharid-Konjugats
DE10324710A1 (de) * 2003-05-30 2004-12-16 Supramol Parenteral Colloids Gmbh Stärkederivatkomplexe

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990015628A1 (fr) * 1989-06-14 1990-12-27 Cetus Corporation Conjugue polymere antibiotique
EP0466038A1 (fr) * 1990-07-12 1992-01-15 E.R. SQUIBB & SONS, INC. Complexes de polyènes antifongiques dispersables à l'eau
WO1998056424A1 (fr) * 1997-06-12 1998-12-17 Ml Laboratories Plc Materiaux presentant une activite biologique

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990015628A1 (fr) * 1989-06-14 1990-12-27 Cetus Corporation Conjugue polymere antibiotique
EP0466038A1 (fr) * 1990-07-12 1992-01-15 E.R. SQUIBB & SONS, INC. Complexes de polyènes antifongiques dispersables à l'eau
WO1998056424A1 (fr) * 1997-06-12 1998-12-17 Ml Laboratories Plc Materiaux presentant une activite biologique

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DUNCAN R ET AL: "Dextrins as Carriers of Anticancer Agents", PROCEEDINGS OF THE 24TH. INTERNATIONAL SYMPOSIUM ON CONTROLLED RELEASE OF BIOACTIVE MATERIALS. STOCKHOLM, JUNE 15 - 19, 1997, PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON CONTROLLED RELEASE OF BIOACTIVE MATERIALS, DEERFIELD, IL., CONTROLLED RELEASE, vol. SYMP. 24, 15 June 1997 (1997-06-15), pages 771 - 772, XP002078115, ISSN: 1022-0178 *
FALK RAMA ET AL: "A novel injectable water-soluble amphotericin B-arabinogalactan conjugate.", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 43, no. 8, August 1999 (1999-08-01), pages 1975 - 1981, XP002182534, ISSN: 0066-4804 *
GERMAN L A ET AL: "Dextrin-amphotericin B: A potential polymeric anti-infective or antiparasitic agent.", JOURNAL OF PHARMACY AND PHARMACOLOGY, vol. 52, no. Supplement, September 2000 (2000-09-01), 137th British Pharmaceutical Conference;Birmingham, England, UK; September 10-13, 2000, pages 37, XP001022489, ISSN: 0022-3573 *
YOUNG D H ET AL: "ANTIFUNGAL PROPERTIES OF TAXOL AND VARIOUS ANALOGUES", EXPERIENTIA, BIRKHAUSER VERLAG. BASEL, CH, vol. 48, no. 9, 1992, pages 882 - 885, XP000929422, ISSN: 0014-4754 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7220414B2 (en) 2000-09-06 2007-05-22 A.P. Pharma, Inc. Degradable polyacetal polymers

Also Published As

Publication number Publication date
AU2001266201A1 (en) 2002-01-14
WO2002002146A2 (fr) 2002-01-10
EP1296719A2 (fr) 2003-04-02

Similar Documents

Publication Publication Date Title
WO2005007197A3 (fr) Molecules biologiques conjuguees et leur preparation
PT1073470E (pt) Composicoes farmaceuticas contendo compostos com actividade capaz de melhorar a absorcao de ingredientes activos
WO2003006425A3 (fr) Nouveaux composes convenant comme anti-inflammatoires, immuno-modulateurs et anti-proliferants
CA2414095A1 (fr) Nouveaux composes
AU2002351124A1 (en) Pyrazoles-pyrimidine fungicides
EP1253142A4 (fr) Composes presentant un agonisme vis a vis du recepteur de la thrombopoietine
WO2002008296A3 (fr) Liants et compositions de liants contenant des groupes alkoxysilyle, procede de fabrication, et utilisation de ceux-ci
DE60004172D1 (de) Gcsf konjugate
CA2425560A1 (fr) Nouveaux anticholinergiques, leurs procedes de production et leur utilisation en tant que compositions pharmaceutiques
PL344012A1 (en) Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
EA200200374A1 (ru) Производные хинолилпропилпиперидина, их получение и содержащие их композиции
WO2004083259A3 (fr) Formes activees de polymeres hydrosolubles
WO2003082798A8 (fr) Composes naturels et leurs derives, destines a la prevention et au traitement de maladies cardiovasculaires, hepatiques, renales, et a des applications cosmetiques
WO2001090071A3 (fr) Iminoazines substituees
WO2001017973A3 (fr) Nouveaux herbicides
EP1340755A4 (fr) Agents de traitement des infections a helicobacter
DK1606242T3 (da) Azidfri fremgangsmåde til fremstilling af 1,2-diaminoforbindelser
CA2367020A1 (fr) Procede de fabrication de formes de dosage solides renfermant de la cyclodextrine
CA2336412A1 (fr) Medicament pour le traitement du diabete
WO2001074918A1 (fr) Composition photodurcissable, objet durci et leur procede de production
WO2002042271A3 (fr) Biphenylcarboxamides utiles comme hypolipidemiants
WO2001012202A3 (fr) Utilisation d'agents chimiques chelatants comme agents de neutralisation du blocage neuromusculaire provoque par des medicaments
SE0101038D0 (sv) Novel compounds
WO2002024697A1 (fr) Composes spiro et inhibiteurs de molecules d'adhesion contenant ces composes comme ingredient actif
EP0947856A3 (fr) Matériau pour lentille oculaire

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2001943663

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001943663

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2001943663

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP